BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35150552)

  • 21. 18F-FDG PET/CT in Hodgkin Lymphoma With Unsuspected COVID-19.
    Boulvard Chollet XLE; Romero Robles LG; Garrastachu P; Cabrera Villegas A; Albornoz Almada MC; Colletti PM; Rubello D; Ramírez Lasanta R; Delgado Bolton RC
    Clin Nucl Med; 2020 Aug; 45(8):652-653. PubMed ID: 32520507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG PET/CT Findings in an Asymptomatic Case of Confirmed COVID-19.
    Martineau P; Kidane B
    Clin Nucl Med; 2020 Aug; 45(8):647-648. PubMed ID: 32433160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [
    Rodríguez-Alfonso B; Ruiz Solís S; Silva-Hernández L; Pintos Pascual I; Aguado Ibáñez S; Salas Antón C
    Rev Esp Med Nucl Imagen Mol; 2021; 40(5):299-309. PubMed ID: 35368611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia.
    Martí A; Morón S; González E; Rojas J
    Biomedica; 2020 Oct; 40(Supl. 2):27-33. PubMed ID: 33152185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT abnormalities evocative of lung infection are associated with lower
    Bahloul A; Boursier C; Jeulin H; Imbert L; Mandry D; Karcher G; Marie PY; Verger A
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):282-286. PubMed ID: 32808079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidental SARS-CoV-2-related findings in asymptomatic patients in [
    Alberts I; Vollnberg B; Sachpekidis C; Mingels C; Weidner S; Afshar-Oromieh A; Rominger A
    Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2068-2069. PubMed ID: 32444898
    [No Abstract]   [Full Text] [Related]  

  • 27. Longitudinal analyses using
    Cong Y; Lee JH; Perry DL; Cooper K; Wang H; Dixit S; Liu DX; Feuerstein IM; Solomon J; Bartos C; Seidel J; Hammoud DA; Adams R; Anthony SM; Liang J; Schuko N; Li R; Liu Y; Wang Z; Tarbet EB; Hischak AMW; Hart R; Isic N; Burdette T; Drawbaugh D; Huzella LM; Byrum R; Ragland D; St Claire MC; Wada J; Kurtz JR; Hensley LE; Schmaljohn CS; Holbrook MR; Johnson RF
    Antiviral Res; 2023 Jun; 214():105605. PubMed ID: 37068595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography/computed tomography scan in the systemic evaluation of patients with post-COVID-19 endogenous presumed fungal endophthalmitis.
    Mehta S; Nagvekar V; Gupta G
    Indian J Ophthalmol; 2021 Oct; 69(10):2873-2874. PubMed ID: 34571657
    [No Abstract]   [Full Text] [Related]  

  • 29. Using 18F-FDG PET/CT to rule out Richter transformation as cause of deterioration in a patient with chronic lymphatic leukemia and severe COVID-19: A case report.
    Fjordside L; Mens H; Asmar A
    Medicine (Baltimore); 2021 Nov; 100(44):e27545. PubMed ID: 34871217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Images of COVID-19 Infection Cases in Asymptomatic or Paucisymptomatic Patients With Neoplastic Diseases on 18F-FDG PET/CT.
    Grellier JF; Lussato D; Guernou M; Queneau M; Bonardel G
    Clin Nucl Med; 2020 Dec; 45(12):965-966. PubMed ID: 32804760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT.
    Sollini M; Gelardi F; Biroli M; Chiti A
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):791-795. PubMed ID: 34928399
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT.
    Krebs S; Petkovska I; Ho AL; Ulaner GA
    Clin Nucl Med; 2020 Aug; 45(8):654-655. PubMed ID: 32433161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG-PET/CT imaging during the Covid-19 emergency: a southern Italian perspective.
    Maurea S; Mainolfi CG; Bombace C; Annunziata A; Attanasio L; Petretta M; Del Vecchio S; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2691-2697. PubMed ID: 32572561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of
    Thornton A; Fraioli F; Wan S; Garthwaite HS; Ganeshan B; Shortman RI; Endozo R; Vöö S; Kayani I; Neriman D; Menezes L; Bomanji J; Hilllman T; Heightman M; Porter JC; Groves AM
    J Nucl Med; 2022 Feb; 63(2):270-273. PubMed ID: 34272318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity.
    Zanoni L; Mosconi C; Cervati V; Diegoli M; Monteduro F; Golfieri R; Fanti S
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):2038-2039. PubMed ID: 32430579
    [No Abstract]   [Full Text] [Related]  

  • 36.
    Qin C; Liu F; Yen TC; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1281-1286. PubMed ID: 32088847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidentally Detected COVID-19 Lung Changes during Oncologic Fluorodeoxyglucose Positron Emission Tomography-Computerized Tomography Studies: Experience from Tertiary Care Cancer Hospital.
    Purandare NC; Prakash A; Shah S; Agrawal A; Puranik AD; Rangarajan V
    Indian J Nucl Med; 2021; 36(4):357-361. PubMed ID: 35125752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma.
    Simand C; Bund C; Guffroy B; Chaban V; Herbrecht R
    Clin Nucl Med; 2020 Aug; 45(8):644-646. PubMed ID: 32520506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19: Incidental Diagnosis by 18F-FDG PET/CT.
    Sinha P; Sinha S; Schlehr E; Schlehr JM
    Clin Nucl Med; 2020 Aug; 45(8):659-660. PubMed ID: 32520510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET/CT and COVID-19.
    Joob B; Wiwanitkit V
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1348. PubMed ID: 32166511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.